Assessment: “We estimate companies covered by the mandate could lose 37% of drivers at a time when the nation is already short 80,000 truck drivers …
The United States Food and Drug Administration (FDA) is warning that supply chain bottlenecks are threatening the availability of over 100 pharmaceutical products.
According to its website, the agency has “asked manufacturers to evaluate their entire supply chain, including active pharmaceutical ingredients, finished dose forms, and any components that may be impacted in any area of the supply chain due to the COVID-19 outbreak.”
“… And there will be famines, pestilences, and earthquakes in various places” Matthew 24:7
Fox Business reported that among the 111 items on backorder are “heart medications, antibiotics, and cancer drugs.”
For the past several months, international supply chains have been disrupted by renewed lockdowns in Asian economies and labor shortages in the United States — preventing consumer goods from reaching American shelves. According to the Council on Foreign Relations, American companies have grown increasingly reliant upon pharmaceutical imports from China and India. As of March 2020, 80% of active pharmaceutical ingredients and 90% of generic medicines come from the two nations.
Beyond pharmaceuticals, the supply chain and labor shortage crises are affecting the defense industry.
